THE four main groups of reticulosis are: (a) Hodgkin's disease; (b) Lymphosarcoma; (c) Reticulum cell sarcoma; (d) Giant follicular lymphoblastoma. I will avoid as far as possible discussion of the leukimias. The material from which my views have been derived consists of cases treated at the Middlesex Hospital from 1930 to 1952.
THE four main groups of reticulosis are: (a) Hodgkin's disease; (b) Lymphosarcoma; (c) Reticulum cell sarcoma; (d) Giant follicular lymphoblastoma. I will avoid as far as possible discussion of the leukimias. The material from which my views have been derived consists of cases treated at the Middlesex Hospital from 1930 to 1952.
We have studied 605 unselected cases, of which 245 were Hodgkin's disease, 186 were lymphosarcoma, 51 were reticulum cell sarcoma, 16 were giant follicular lymphoblastoma.
In addition there were a further 107 cases in which histological proof was lacking or which, by reason of their atypical microscopical appearance, did not fall clearly into these four well-differentiated groups.
Radiotherapy has played a prominent part in the treatment of this whole series of cases and it does not therefore provide material with adequate controls for a true scientific assessment of the value of radiotherapy as opposed to chemotherapy. Chemotherapy, mainly in the form of nitrogen mustard, was used only in the last five to six years of the twenty-twoyear period during which the cases were treated and even then it was used, as the primary method of treatment, only in cases where the disease had generalized manifestations and in no cases where the disease was apparently localized to a single primary focus or a single group of lymph nodes. I should like to make clear at the outset that whatever main method of treatment is employed it must be accompanied constantly by general supportive treatment. Blood transfusion is frequently necessary and skilled nursing is essential. I do not consider that radiotherapy and chemotherapy are competitive methods of treatment in these groups of diseases but rather that they both have a valuable place and that it is important to decide in what circumstances the one or the other, or both, should be used.
With these reservations I consider that radiotherapy should be used as the primary method of treatment in all cases where the disease is apparently localized to a single primary focus or to one group of lymph nodes.
In those cases where the patient presents with involvement of nodes in several regions, e.g. both sides of the neck, the axille, and the mediastinum, radiotherapy should still be used unless there is evidence of more generalized disease with marked constitutional symptoms.
In almost all the cases in these groups of reticulosis the local lesions are initially markedly radiosensitive and disappear with moderate dosage without the production of severe reactions. After a variable time, recurrence mav appear either in the same or in other sites, but can be made to disappear in the same way. Each succeeding relapse tends to be less sensitive to radiation. It may be necessary to increase the dose and even then resolution may be less complete. As the disease becomes generalized it may become unresponsive to radiotherapy. It may then be impossible to treat the extensive involvement without causing damage rather than improvement to the patient's general health. Chemotherapy, by the use of various cytotoxic substances, particularly the nitrogen mustards, is also effective in causing regression of such local lesions, but those compounds which are effective are also generally toxic and may cause general reactions with nausea, vomiting and depression of the white cell count. By their administration tumours can be made to disappear and infiltrations to regress, but I consider that, with rare exceptions, resolution is less complete than with radiotherapy and the period of remission is usually of shorter duration. Nitrogen mustard and allied compounds have a definite place of value in the later stages when the disease has become generalized; at this stage radiotherapy would involve the treatment of large volumes of tissue and the lesions in many instances have ceased to respond to irradiation. Chemotherapy is also of value in those cases presenting initially with evidence of generalized disease, unexplained pyrexia, pruritus, night sweats, perhaps with splenic enlargement and multiple lymph-node involvement.
Many of these patients eventually die with evidence of generalized marrow failure, perhaps through infiltration by tumour cells but frequently from an aplasia the causation of which may be in part due to repeated treatment by radiation or by cytotoxic poisons. I consider that it is advisable to avoid as long as possible those methods of treatment which have a generalized depressing effect on the bone-marrow and that chemotherapy should not be used for the treatment of localized disease when a more local method of treatment is effective.
Owing to its greater flexibility in technique, X-ray therapy is the usual method of radiotherapy which is used in the treatment of these diseases, though teleradium and moulded gamma-ray applicators may sometimes be of value for localized deposits. The usual Proceedings of the Royal Society of Medicine 14 quality of X-rays is a beam generated in the 200 to 250 kilovolt range with a half-value layer of about 2 mm. copper. There are various techniques by which it may be given:
(1) It may be used as a localized irradiation limited to the enlarged glandular masses. If one group of nodes only is involved then that only would be treated. If there are multiple sites of involvement, e.g. both axillie and mediastinum, the treatment would be localized to each of these areas.
(2) In addition to local treatment of involved nodes, so-called prophylactic irradiation of the nearest lymphatic drainage areas has been used. As described by the Toronto school this technique is reported to have caused a definite improvement in results.
(3) X-ray therapy can be given as a regional treatment to include not only the affected organ or group of nodes, but also the surrounding tissues and the neighbouring apparently unaffected node groups. An example of this would be the treatment of the whole abdomen when mesenteric glands are involved. Levitt has described the details of his X-ray bath technique-there may a thoracic bath, an abdominal bath or a total trunk bath.
Consideration of the 245 cases of Hodgkin's disease in our series will best exemplify the principles which I have suggested.
There was a five-year survival of 30% from the whole group. My colleagues A. M.
Jelliffe and A. D. Thomson are at present engaged in making a more detailed study of these cases. They have found that among the patients who, following radiotherapy, have survived more than five years without developing any sign of recurrence, there were some who had only one group of nodes involved at the time of treatment, but there were others who had more than one group of nodes involved. Although the prognosis becomes much worse when deeper glands are involved, there are some cases who have had prolonged remission as long as ten years after irradiation of enlarged mediastinal glands.
Diffuse lung infiltration usually occurs only in the later stages of the disease and does not respond well to irradiation. Localized masses in the lung also do not respond well.
Skin involvement with nodular lesions responds rapidly to irradiation. Generalized pruritus which may occur, particularly when intra-abdominal glands are involved, is variable in response. It may be severe and intractable and may be an indication for chemotherapy.
Bone involvement occurs probably in as much as 15 to 20% of cases. Both osteoblastic and osteoclastic types of involvement occur and both may be present in the same patient and even in the same bone. Pain can be relieved by radiotherapy in the majority of cases. Extradural deposits with or without involvement of vertebra may call for urgent decompression and then can be controlled by localized irradiation.
There is a considerable variation in the views of radiotherapists as to the level of dosage that should be given. It is taught by many that the dose should be sufficient only to cause clinical disappearance of deposits, a dose of 1,200 to 1,500 r in twelve to fourteen days. This can be achieved with only a mild erythema and the skin remains relatively undamaged. This treatment can be repeated when local recurrence occurs, as it frequently will do. I believe that higher dosage has a place in those cases where involvement is limited clinically to one or two adjacent groups of nodes. In such cases we give a dose of 3,000 to 4,000 r incident over three to four weeks. It appears that when this type of dosage has been used in early lesions we have obtained our longest survivors. Local recurrence is rare in the areas so treated, although there may be recurrence in the same area at a later date when the disease becomes generalized. This method of treatment is comparable to surgical removal and appears to be as effective. Of 8 patients who survived more than five years without any recurrence, 6 had doses of 3,000 r and over. Of 16 patients whose first recurrence was in the area previously treated, in only 3 was the dose up to 3,000 r and in none was it above this figure. Although the five-year survival rate of the whole group is 30%, for the years 1937 to 1947 after this more intensive treatment was started, the five-year survival rate was 36 %.
When there are several areas involved high dosage of this order cannot be used and when regional or bath treatment is used with a high integral or total body dose the dose level is much lower. I have not personally had any striking success with the bath method of treatment advocated by Levitt, and for the reasons which I have given prefer to keep to local irradiation as long as possible and then to use chemotherapy when the disease becomes generalized.
There were 186 cases of lymphosarcoma with a five-year survival rate of 15 %. 15 % of them came with primary lesions in a mucosal surface, the tonsil, nasopharynx or in the gut wall. Glands in the mediastinum or abdomen may progress rapidly and cause pressure symptoms such as vena caval or tracheal obstruction. Some of our cases of lymphosarcoma have progressed into lymphatic leukemia. Some have had a leukiemoid blood picture when first seen. Some cases of lymphosarcoma have developed from giant follicular lymphoblastoma. We have not yet divided up our cases of lymphocytic and lymphoblastic lymphosarcoma, but the lymphoblastic ones appear to have a more rapid course and worse prognosis. We consider that localized lesions need localized high dosage of radiation. There is then some chance of cure which may perhaps even be a lasting one. The most favourable types are those with primary lesions in the tonsil, tongue and nasopharynx. They are most appropriately dealt with by localized irradiation which includes the immediate lymphatic drainage areas.
The majority of cases of lymphosarcoma are very radiosensitive but some do not respond and in particular some cases of bone involvement have been found to be resistant.
Radiotherapy is of the greatest value as a palliative in some cases to obtain rapid relief of pressure symptoms.
We have used nitrogen mustard and other cytotoxic compounds with symptomatic improvement in cases with generalized disease.
Reticulum cell sarcoma has the worst prognosis of all. 20 % of our cases had local mucosal lesions in the mouth or pharynx which appeared as a sloughing ulcer or hypertrophic sloughing mass. It may occur primarily in the bowel wall or in mesenteric glands. 16 % presented as acute abdomen.
There may be skin lesions which may be nodular and localized or may be generalized with exfoliative dermatitis. Bone involvement may occur at any stage. They are the most rapid in their development and it may be possible to notice even a daily increase in size.
I consider that these cases should be treated on the same lines as I have suggested for lymphosarcoma. The majority are extremely radiosensitive but some do not respond to even high dosage.
My experience of giant follicular lymphoblastoma is limited to 26 cases: to the 16 cases referred to a further 10 have now been added. They have presented in almost all cases as a local glandular enlargement which may be a single node and may be large and conspicuous.
They tend to progress with involvement of mediastinal and abdominal glands with a tendency to serous effusions. All our cases have been markedly radiosensitive and they have been relatively benign over a number of years. Generalization does not appear to give the same bad prognosis as in the other types of reticuloses which I have discussed. They have not appeared to become more radioresistant if different groups of nodes become involved but some have changed into lymphosarcoma and some have developed a leukxemoid blood picture.
Summary I have suggested that in these conditions radiotherapy is indicated for localized disease and that chemotherapy should be reserved for generalized manifestations.
In Hodgkin's disease and in giant follicular lymphoblastoma radiotherapy will cause longer and more complete remission. In localized lymphosarcoma and reticulum cell sarcoma it gives a chance of cure.
For palliative purposes radiotherapy is usually more rapid and more certain in securing regression of a local mass.
Radiotherapy if used as a localized treatment, even if applied to multiple regions, is less likely to cause generalized damage and exhaustion of bone-marrow.
Both these methods have a valuable place and must be used in conjunction with one another. MANAGEMENT of advanced cancer is in many ways a greater problem than treatment of any given case. It includes the day-to-day supervision by the general practitioner as well as the highly specialized methods of treatment often needed for the control of pain and the maintenance of life.
The Management of Advanced Cancer
Management varies from patient to patient and depends on the nature of the tumour, the site and distribution of lesions, the functional disabilities and the general effects, such as wasting, anxmia and fever.
The main object is the preservation of life with the minimum of symptoms and should result in objective and subjective alleviation.
Advanced cancer implies in all cases extension of disease beyond its site of origin to adjoining tissues and organs and always results in the end in a multiplicity of symptoms due to the metastatic spread. It presents an ever-varying clinical picture; a constant, although often slow, change of emphasis from one disability to another. Thus the management of any given patient often needs the services of different specialties and a different approach in the ;progressive stages of the disease. The available methods of treatment include surgery radiotherapy, chemotherapy, hormonal control, symptomatic relief by drugs and a combination of any of these therapeutic measures.
